Indian government during the time of global pandemic is trying to help remote areas to get vaccinated. BHARAT BIOTECH along with SII is going to expand their help to IRAN (10 LAKH DOSES), and Indian remote areas under the program- “VACCINE MAITRI”.
(Vaccine Maitri” is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. The government started providing vaccines, India had delivered around 66.3 million doses of vaccines to 95 countries).
SII (SERUM INSTITUTE OF INDIA)-a Pune based PHARMA COMPANY is now officially noticed to export 10 lakh COVISHIELD (this vaccine is made in collaboration with OXFORD UNIVERSITY and ASTRAZENECA) doses each to NEPAL, BANGLADESH, and MYANMAR along with this, 3 crore vaccines to AstraZeneca (UK) have been issued.
“while 10 lakh doses of Bharat Biotech’s Covaxin would be sent to Iran, serum institute of India will export 10 lakh doses of covishield each to Myanmar, Nepal, and Bangladesh under the “Vaccine Maitri” program in October,” an official told PTI.
SII informed the centre they are going to enhance their supply and will be able to provide 22 crore doses at the end of October and 66 crores by the end of December, after this they will touch supplies of more than 130 crores by the end of 2021.
Bharat biotech by the upcoming months going to enhance their production of COVAXIN (an indigenously prepared in collaboration with ICMR-Indian Council Of Medical Research) from 3 crores to 5 crores.
ICMR this Tuesday launched a drone-based vaccine delivery system in collaboration with IIT KANPUR
The model is based on the quick and safe delivery of the doses, at a time the(i-drone) is designed to carry a stack of 900 doses in a single fly.
This is the first time that a Make in India drone has been used to transport COVID vaccine over an aerial distance of 15km in 12-15mins
The technology may prove to be a game-changer in critical situations in health care delivery in difficult areas too.
Also Read – Ex-chief of military intelligence and son set up firm in Seychelles, secured inflow at $1 mn